(Q28375031)

English

Role of lamivudine in the treatment of chronic hepatitis B virus infection

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Role of lamivudine in the treatment of chronic hepatitis B virus infection (English)

0 references

1 reference

1 reference

1 reference

1 reference

K O Hagmeyer

1

0 references

Y Y Pan

series ordinal

2

0 references

language of work or name

English

0 references

publication date

October 1999

0 references

published in

Annals of Pharmacotherapy

0 references

volume

33

0 references

issue

10

0 references

page(s)

1104-12

0 references

cites work

Hepatitis B: Evolving Epidemiology and Implications for Control

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

The treatment of chronic viral hepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Therapy of chronic viral hepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Therapy of viral hepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

A practical guide to the use of interferons in the management of hepatitis virus infections

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Treatment of fibrosing cholestatic hepatitis with lamivudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.18452

retrieved

21 January 2018

Identifiers

DOI

10.1345/APH.18452

0 references

PubMed publication ID

10534223

0 references

ResearchGate publication ID

12766866

0 references

(Q28375031)

Role of lamivudine in the treatment of chronic hepatitis B virus infection

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)